Join the Rucaparib group to help and get support from people like you.
Rucaparib News
Rucaparib Could Extend Survival for Uterine Cancer Patients
FRIDAY, March 22, 2024 – An already approved cancer drug could be an effective treatment for women with advanced, recurring uterine cancer, a new clinical trial shows. Rucaparib, which belongs to a...
Rubraca (rucaparib) Approved in the U.S. as Monotherapy Treatment for Patients with BRCA1/2-Mutant, Metastatic Castration-Resistant Prostate Cancer (mCRPC)
BOULDER, Colo.--(BUSINESS WIRE)--May 15, 2020 – Clovis Oncology, Inc. (NASDAQ: CLVS), announced today that the U.S. Food and Drug Administration (FDA) approved Rubraca® (rucaparib) tablets for the ...
Rubraca (rucaparib) Approved in the U.S. as Maintenance Treatment of Recurrent Ovarian Cancer
BOULDER, Colo.--(BUSINESS WIRE)--Apr. 6, 2018-- Clovis Oncology, Inc. (NASDAQ:CLVS) today announced that the U.S. Food and Drug Administration (FDA) has approved Rubraca (rucaparib) tablets for the...
FDA Grants Accelerated Approval to Rubraca (rucaparib) for Advanced Ovarian Cancer
December 19, 2016 – The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer. Rubraca is approved for...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Ovarian Cancer, Prostate Cancer